Connection

William Groh to Aged

Back to Details
This is a "connection" page, showing publications William Groh has written about Aged.
William Groh
Connection Strength
0.308
Aged
  1. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population. J Cardiovasc Electrophysiol. 2011 Dec; 22(12):1369-75.
    View in: PubMed
    Score: 0.032
  2. A retrospective analysis of proceduralist-directed, nurse-administered propofol sedation for implantable cardioverter-defibrillator procedures. Heart Rhythm. 2012 Mar; 9(3):342-6.
    View in: PubMed
    Score: 0.032
  3. Survival and CTG repeat expansion in adults with myotonic dystrophy type 1. Muscle Nerve. 2011 May; 43(5):648-51.
    View in: PubMed
    Score: 0.031
  4. Physical function of patients with implantable cardioverter-defibrillators. J Cardiovasc Nurs. 2009 Sep-Oct; 24(5):398-409.
    View in: PubMed
    Score: 0.027
  5. Pacemaker/implantable cardioverter-defibrillator problem: right ventricular lead missensing in a biventricular implantable cardioverter-defibrillator. Heart Rhythm. 2008 Jan; 5(1):158-9.
    View in: PubMed
    Score: 0.024
  6. Factors associated with poor survival in women experiencing cardiac arrest in a rural setting. Heart Rhythm. 2005 May; 2(5):492-6.
    View in: PubMed
    Score: 0.020
  7. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J. 2004 Feb; 147(2):224-7.
    View in: PubMed
    Score: 0.019
  8. Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1. Ann Noninvasive Electrocardiol. 2003 Jul; 8(3):227-32.
    View in: PubMed
    Score: 0.018
  9. Attitudes of law enforcement officers regarding automated external defibrillators. Acad Emerg Med. 2002 Jul; 9(7):751-3.
    View in: PubMed
    Score: 0.017
  10. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol. 2002 May; 13(5):444-8.
    View in: PubMed
    Score: 0.016
  11. Limited response to cardiac arrest by police equipped with automated external defibrillators: lack of survival benefit in suburban and rural Indiana--the police as responder automated defibrillation evaluation (PARADE). Acad Emerg Med. 2001 Apr; 8(4):324-30.
    View in: PubMed
    Score: 0.015
  12. Amiodarone reduces the prevalence of T wave alternans in a population with ventricular tachyarrhythmias. J Cardiovasc Electrophysiol. 1999 Oct; 10(10):1335-9.
    View in: PubMed
    Score: 0.014
  13. Software error resulting in malfunction of an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 1999 Jun; 10(6):871-3.
    View in: PubMed
    Score: 0.013
  14. Evaluation of the Genetic Basis of Familial Aggregation of Pacemaker Implantation by a Large Next Generation Sequencing Panel. PLoS One. 2015; 10(12):e0143588.
    View in: PubMed
    Score: 0.011
  15. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region. Heart Rhythm. 2014 May; 11(5):849-55.
    View in: PubMed
    Score: 0.009
  16. A pilot study in hemodialysis of an electrophysiological tool to measure sudden cardiac death risk. Clin Nephrol. 2007 Sep; 68(3):159-64.
    View in: PubMed
    Score: 0.006
  17. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol. 2000 Dec; 36(7):2247-53.
    View in: PubMed
    Score: 0.004
  18. [5-years experience with pacemaker therapy]. Orv Hetil. 1971 Aug 22; 112(34):2007-10.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.